ARQT vs AAPL: Which Stock is Better?
Side-by-side comparison of Arcutis Biotherapeutics Inc and Apple Inc in 2026
ARQT
Arcutis Biotherapeutics Inc
$23.85
AAPL
Apple Inc
$325.46
Key Metrics Comparison
| Metric | ARQT | AAPL | Winner |
|---|---|---|---|
| Market Cap | $1.64B | $3.83T | AAPL |
| P/E Ratio | N/A | 34.84 | AAPL |
| EPS (TTM) | $N/A | $7.47 | AAPL |
| Revenue Growth | 0.0% | 7.9% | AAPL |
| Gross Margin | 0.0% | 46.9% | AAPL |
Analyze ARQT
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARQT or AAPL a better investment?
Comparing ARQT and AAPL: Arcutis Biotherapeutics Inc has a market cap of $1.64B while Apple Inc has $3.83T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARQT and AAPL?
ARQT (Arcutis Biotherapeutics Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARQT or AAPL?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARQT or AAPL?
AAPL has higher revenue growth at 7.9% vs 0.0% for ARQT.
Which company is more profitable: ARQT or AAPL?
Apple Inc (AAPL) has higher gross margins at 46.9% compared to 0.0% for ARQT.
Which is the larger company: ARQT or AAPL?
Apple Inc (AAPL) is larger with a market cap of $3.83T compared to $1.64B for ARQT.
Should I buy ARQT or AAPL in 2026?
Both ARQT and AAPL have investment merit. ARQT trades at $23.85 while AAPL trades at $325.46. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARQT and AAPL stock?
Key differences: Market Cap ($1.64B vs $3.83T), P/E Ratio (N/A vs 34.8x), Revenue Growth (0.0% vs 7.9%), Gross Margin (0.0% vs 46.9%).
Should I buy ARQT or AAPL in 2026?
The choice between ARQT and AAPL depends on your investment goals. AAPL shows higher revenue growth (7.9%). AAPL has better margins (46.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between ARQT and AAPL?
ARQT (Arcutis Biotherapeutics Inc) has a market cap of $1.64B, while AAPL (Apple Inc) has a market cap of $3.83T. AAPL is the larger company by market value.